SITC has provided comment on the recently posted "Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Studies; Guidance for Industry - Draft Guidance". SITC was pleased to see FDA incorporate feedback and topics that have stemmed from recent...
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us